Companies House · 06151086

BIOGEN LTD

UK registered company, private limited company, incorporated 12 Mar 2007.

Active
35
Public contracts
0
Spend payments
Total spend

BIOGEN LTD is a UK company registered at Companies House under number 06151086. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
06151086
Status
Active
Company type
Private Limited Company
Incorporated
12 Mar 2007
Country of origin
United Kingdom
Registered office
MILTON PARC, MILTON ERNEST, MK44 1YU
Nature of business (SIC)
74990 - Non-trading company
Accounts category
DORMANT
View source on data.gov.uk

Public sector contracts

Contract awards linked to BIOGEN LTD.

ProcurementBuyerAwardedValue
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
National Framework Agreement for Adalimumab Injection 1 April 2023NHS England
NHS Framework for Midlands and East Branded Medicines - Tranche B and Annual TrancheNHS England
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS National Framework for NatalizumabNHS England
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025NHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025NHS England30 Jun 2025£986.3m
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024NHS England24 Jul 2024£416.8m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Framework Agreement for the supply of Ranibizumab for the NHS in EnglandNHS England31 Mar 2023£70m
NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023NHS England3 Mar 2023£264m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework for the NHS London Region, Branded Medicines - Tranche ANHS England16 Jun 2020£191.1m
NHS National Framework Agreement for Adalimumab InjectionNHS England6 Mar 2020£445m
NHS Framework Agreement - North of England - Tranche BNHS England13 Feb 2020£205.5m
NHS South of England Branded Medicines - Tranche ANHS England31 Jul 2019£188m
Provision of Recycling StreamsLondon Borough Of Bexley27 Jul 2019£16.5m
NHS Framework Agreement - North of England - Tranche BNHS England13 Feb 2018£521.1m

Supplier identities

How this company appears as a supplier across the data.

FAQs about BIOGEN LTD

Is BIOGEN LTD an active company?

BIOGEN LTD (company number 06151086) is recorded as "Active", incorporated on 12 Mar 2007.

What does BIOGEN LTD do?

Its Companies House nature-of-business (SIC) is: 74990 - Non-trading company.

Has BIOGEN LTD won UK public-sector contracts?

Yes — 35 public-sector contract awards are linked to this company in our data.

Where is BIOGEN LTD based?

Its registered office is MILTON PARC, MILTON ERNEST, MK44 1YU.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable